How many employees work at Square Pharmaceuticals?
Square Pharmaceuticals Plc (SQURPHARMA) has approximately 16,129 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Square Pharmaceuticals’s total headcount has grown 10.3% from 14,628 employees in 2023 to 16,129 in 2026.
About Square Pharmaceuticals’s Workforce
Square Pharmaceuticals Plc (SQURPHARMA) is a Pharmaceuticals company that employs 16,129 people worldwide as of March 2026. It is the 8th-largest by headcount among its peers. Founded in 1958, the company is headquartered in Dhaka, Bangladesh and trades on the Dhaka Stock Exchange.
Square Pharmaceuticals's workforce has grown 10.3% from 2023 to 2026. Its workforce is concentrated most in South Asia (97.2%), followed by Sub-Saharan Africa (2.4%) and North America (0.2%).
Square Pharmaceuticals's functional groups are Engineering (42.4%), Finance and Operations (32.7%), and Sales and Marketing (25.0%), with Finance and Operations growing fastest (up 3.7%). The average salary is $8,235, ranging from a median of $56,000 in Western Europe to $6,000 in South Asia, down 1.7% year over year in 2026.
Overall employee sentiment is neutral but declining.
Sourced from Revelio Labs workforce data.
- Ticker
- Dhaka Stock Exchange: SQURPHARMA
- Headquarters
- Dhaka, Bangladesh
- Founded
- 1958
- Industry
- Pharmaceuticals
- Employees
- 16,129
- YoY
- +0.0% (+318)
As of March 2026
Square Pharmaceuticals workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Square Pharmaceuticals. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsSquare Pharmaceuticals Annual Employee Count (2023-2026)
- Square Pharmaceuticals had 16,129 employees in 2026, a 0% no change (+318) from 2025.
- Square Pharmaceuticals had 16,124 employees in 2025, a 1.4% increase (+663) from 2024.
- Square Pharmaceuticals had 15,461 employees in 2024, a 0.7% increase (+590) from 2023.
- Square Pharmaceuticals had 14,871 employees in 2023, a 1.0% increase (+510) from 2022.
Square Pharmaceuticals's total workforce has grown from 14,628 employees in 2023 to 16,129 in 2026.
Square Pharmaceuticals Plc quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 16,129 | +318 | +0.0% |
| 2025 | Q4 | 16,124 | +663 | +1.4% |
| 2025 | Q3 | 15,867 | +731 | +1.5% |
| 2025 | Q2 | 15,859 | +679 | +0.7% |
| 2025 | Q1 | 15,811 | +843 | +1.7% |
| 2024 | Q4 | 15,461 | +590 | +0.7% |
| 2024 | Q3 | 15,136 | +348 | +0.3% |
| 2024 | Q2 | 15,180 | +552 | +1.4% |
| 2024 | Q1 | 14,968 | +574 | +1.5% |
| 2023 | Q4 | 14,871 | +510 | +1.0% |
| 2023 | Q3 | 14,788 | +522 | +1.5% |
| 2023 | Q2 | 14,628 | +339 | +1.0% |
See Square Pharmaceuticals's complete headcount history, including quarterly breakdowns.
Get the DataSquare Pharmaceuticals Employee Count by Region (2026)
South Asia accounts for the largest share of Square Pharmaceuticals's global workforce with approximately 97% of total employees, followed by Sub-Saharan Africa and North America.
Square Pharmaceuticals employees by region
| Region | Employees | % of Total |
|---|---|---|
| South Asia | 15,551 | 97.2% |
| Sub-Saharan Africa | 377 | 2.4% |
| North America | 27 | 0.2% |
| Arab States | 16 | 0.1% |
| South America | 9 | 0.1% |
| Southern Europe | 8 | 0.0% |
| Western Europe | 7 | 0.0% |
| Eastern Europe | 2 | 0.0% |
| Northern Europe | 2 | 0.0% |
| Southeast Asia | 2 | 0.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataSquare Pharmaceuticals Employee Count by Department (2026)
Square Pharmaceuticals's employee groups are Engineering (42.4%), Finance and Operations (32.7%), and Sales and Marketing (25.0%).
Square Pharmaceuticals employees by department
| Department | Employees | % of Total |
|---|---|---|
| Engineering | 6,803 | 42.4% |
| Finance and Operations | 5,244 | 32.7% |
| Sales and Marketing | 4,012 | 25.0% |
Compare Square Pharmaceuticals's department mix to industry peers.
See Full DataSquare Pharmaceuticals Employee Salary by Region (2026)
Square Pharmaceuticals's average employee salary is $8,235 globally. Employees in Western Europe receive the highest compensation, with median pay approximately 6.8x the global average. Pay is lowest in South Asia, at a median of $6,000.
Square Pharmaceuticals median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| Western Europe | $56,000 |
| North America | $54,000 |
| Arab States | $13,000 |
| Sub-Saharan Africa | $9,000 |
| South Asia | $6,000 |
Unlock salary by role, level, and city — and compare to Square Pharmaceuticals's industry peers.
Unlock Salary DataSquare Pharmaceuticals Employee Sentiment (2026)
Revelio Labs tracks employee sentiment across Square Pharmaceuticals's workforce based on public professional data. Overall sentiment is neutral and has declined year over year in 2026.
Overall
Unlock the full sentiment breakdown by department, tenure, and trend over time.
Unlock SentimentSimilar Companies
Similar Pharmaceuticals Companies by Employee Count
Frequently Asked Questions About Square Pharmaceuticals
- How fast is Square Pharmaceuticals growing?
- In 2026, Square Pharmaceuticals's headcount grew 0.0% to 16,129 employees, up from 15,811 in 2025.
- See the full headcount history
- Where are Square Pharmaceuticals employees located?
- Most Square Pharmaceuticals employees are based in South Asia (97.2% of headcount), followed by Sub-Saharan Africa and North America.
- Explore where the workforce is based
- What is the average salary at Square Pharmaceuticals?
- The average employee salary at Square Pharmaceuticals is approximately $8.2k per year.
- Analyze the salary distribution
- When was Square Pharmaceuticals founded and where is it headquartered?
- Square Pharmaceuticals was founded in 1958 and is headquartered in Dhaka, Bangladesh.
- Compare Square Pharmaceuticals to industry peers
Speak with a workforce expert about Square Pharmaceuticals.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.